Citation Impact
Citing Papers
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
2005 Standout
Activity of SU11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor Receptor, in Patients With Metastatic Renal Cell Carcinoma
2005 Standout
Nuclear Lamin-A Scales with Tissue Stiffness and Enhances Matrix-Directed Differentiation
2013 StandoutScience
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Evolution of the Cancer Stem Cell Model
2014 Standout
Anti-tissue transglutaminase antibodies from coeliac patients inhibit transglutaminase activity both in vitro and in situ
2002 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
The Corticosteroid Receptor Hypothesis of Depression
2000 Standout
AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis
1996 Standout
Partial chromosome 21 amplification in a child with acute lymphoblastic leukemia
1995
The role of FLT3 in haematopoietic malignancies
2003
Identification of tissue transglutaminase as the autoantigen of celiac disease
1997 Standout
Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
2012 Standout
A Mechanism for Regulating Pulmonary Inflammation and Fibrosis: The Integrin αvβ6 Binds and Activates Latent TGF β1
1999 Standout
Cytogenetics in acute leukemia
2003
Localization of cellular transglutaminase on the extracellular matrix after wounding: Characteristics of the matrix bound enzyme
1991
Acute Lymphoblastic Leukemia
1998
Acute lymphoblastic leukaemia
2013
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
2007 Standout
Cancer stem cells revisited
2017 Standout
The Oncogenic Cysteine-rich LIM domain protein Rbtn2 is essential for erythroid development
1994 StandoutNobel
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial
2006 Standout
Delivery of c-myb Antisense Oligodeoxynucleotides to Human Neuroblastoma Cells Via Disialoganglioside GD2-Targeted Immunoliposomes: Antitumor Effects
2000
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
In vivo and in vitro induction of ‘tissue’ transglutaminase in rat hepatocytes by retinoic acid
1992
Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease
1999
Transglutaminases: crosslinking enzymes with pleiotropic functions
2003 Standout
The novel homeoprotein Prep1 modulates Pbx-Hox protein cooperativity
1998
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
2007 Standout
Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program
2003
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
Targeting multiple signal transduction pathways through inhibition of Hsp90
2004
Clinical aspects of glucocorticoid sensitivity
1996
The cancer stem cell: premises, promises and challenges
2011 Standout
Childhood Leukemias
1995
Point mutations of protein kinases and individualised cancer therapy
2006
The Management of Neoplastic Disorders of Haematopoeisis in Children with Down's Syndrome
2000
Lestaurtinib, a multitargeted tyrosinse kinase inhibitor: from bench to bedside
2010
In vivo treatment of mutant FLT3-transformed murine leukemia with a tyrosine kinase inhibitor
2000 StandoutNobel
Clinical and biological importance of cytogenetic abnormalities in childhood and adult acute lymphoblastic leukemia
2004
The STATs of cancer — new molecular targets come of age
2004 Standout
Down's syndrome
2003 Standout
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
The anti-angiogenic basis of metronomic chemotherapy
2004 Standout
A census of human cancer genes
2004 Standout
Macrophage Cytokines: Involvement in Immunity and Infectious Diseases
2014 Standout
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
2009 Standout
Childhood acute lymphoblastic leukemia
2002
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
2005 StandoutNature
PVF2, a PDGF/VEGF‐like growth factor, induces hemocyte proliferation in Drosophila larvae
2002 StandoutNobel
A Pilot Study of Idiotypic Vaccination for Follicular B-cell Lymphoma Using a Genetic Approach. University of Bristol, Bristol, United Kingdom
1997 StandoutNobel
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
1999 StandoutScience
Constitutive activation of FLT3 in acute myeloid leukaemia and its consequences for growth of 32D cells
2000
Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86
1994
Acute Myeloid Leukemia
2015 Standout
Differences in signaling pathways by IL-1β and IL-18
2004
Idiotypic vaccination against human B-cell lymphoma. Rescue of variable region gene sequences from biopsy material for assembly as single-chain Fv personal vaccines
1994 StandoutNobel
Protein Crosslinking in Assembly and Remodelling of Extracellular Matrices: The Role of Transglutaminases
2000
Expression of tissue transglutaminase in Balb-C 3T3 fibroblasts: effects on cellular morphology and adhesion.
1992
Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia
2004
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
2009 Standout
A Common NLRC4 Gene Variant Associates With Inflammation and Pulmonary Function in Human Immunodeficiency Virus and Tuberculosis
2019 StandoutNobel
Tyrosine kinase oncogenes in normal hematopoiesis and hematological disease
2002
The roles of FLT3 in hematopoiesis and leukemia
2002
The binding sites on fibrin(ogen) for guinea pig liver transglutaminase are similar to those of blood coagulation factor XIII. Characterization of the binding of liver transglutaminase to fibrin.
1988
Differential expression of tissue transglutaminase in human cells
1989
Cancer treatment and survivorship statistics, 2016
2016 Standout
The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials
2001 Standout
Rapid and selective death of leukemia stem and progenitor cells induced by the compound 4-benzyl, 2-methyl, 1,2,4-thiadiazolidine, 3,5 dione (TDZD-8)
2007
A FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in vitro and in vivo
2002
Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells.
1993
Cancer treatment and survivorship statistics, 2019
2019 Standout
Increased Frequency of Surface IgA-Positive Plasma Cells in the Intestinal Lamina Propria and Decreased IgA Excretion in Hyper IgA (HIGA) Mice, a Murine Model of IgA Nephropathy with Hyperserum IgA
2000 StandoutNobel
Natural product and natural product derived drugs in clinical trials
2014 Standout
Immunobiology of Dendritic Cells
2000 Standout
Molecular Genetics of Acute Lymphoblastic Leukemia
2005
Unmutated Ig VH Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic Leukemia
1999 Standout
SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo
2003
Isolation and characterization of cDNA clones to mouse macrophage and human endothelial cell tissue transglutaminases.
1991
Overlapping roles of two Hox genes and theexdorthologceh-20in diversification of theC. eleganspostembryonic mesoderm
2000 StandoutNobel
c-kit Ligand and Flt3 Ligand: Stem/Progenitor Cell Factors With Overlapping Yet Distinct Activities
1998
Transglutaminases: multifunctional cross‐linking enzymes that stabilize tissues
1991 Standout
Identification and characterization of plasma cells in normal human bone marrow by high-resolution flow cytometry
1990
Acute lymphoblastic leukemia with low hypodiploid/near triploid karyotype is a specific clinical entity and exhibits a very high TP53 mutation frequency of 93%
2014
Current status of cytogenetic research in childhood acute lymphoblastic leukemia
1993
Formation of high molecular weight dermatan sulfate proteoglycan in bovine aortic endothelial cell cultures. Evidence for transglutaminase-catalyzed cross-linking to fibronectin.
1990
Tissue (type II) transglutaminase covalently incorporates itself, fibrinogen, or fibronectin into high molecular weight complexes on the extracellular surface of isolated hepatocytes. Use of 2-[(2-oxopropyl)thio] imidazolium derivatives as cellular transglutaminase inactivators.
1991
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
1999 StandoutScience
A phase 2 trial of the FLT3 inhibitor lestaurtinib (CEP701) as first-line treatment for older patients with acute myeloid leukemia not considered fit for intensive chemotherapy
2006
Flow cytometric immunophenotyping for hematologic neoplasms
2008
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
The evolving role of FLT3 inhibitors in acute myeloid leukemia: quizartinib and beyond
2014
Leukemic cell growth in SCID mice as a predictor of relapse in high- risk B-lineage acute lymphoblastic leukemia
1995
Cancer treatment and survivorship statistics, 2014
2014 Standout
Works of MJ Borowitz being referenced
The transglutaminase in vascular cells and tissues could provide an alternate pathway for fibrin stabilization
1987
Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing’s sarcoma
1998
Trisomy 21 in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study (8602)
1993
Immunoglobulin and T cell receptor gene rearrangements in human lymphoma and leukemia
1987
Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: a Pediatric Oncology Group study
1992
The transglutaminase in vascular cells and tissues could provide an alternate pathway for fibrin stabilization
1987
Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: a Pediatric Oncology Group study
1992
Predictability of the t(1;19)(q23;p13) from surface antigen phenotype: implications for screening cases of childhood acute lymphoblastic leukemia for molecular analysis: a Pediatric Oncology Group study
1993
Near-triploid and near-tetraploid acute lymphoblastic leukemia of childhood
1990
Clinical and biological heterogeneity of childhood B cell acute lymphocytic leukemia: implications for clinical trials.
1990
Expression of the hematopoietic growth factor receptor FLT3 (STK- 1/Flk2) in human leukemias
1996
High glucocorticoid receptor content of leukemic blasts is a favorable prognostic factor in childhood acute lymphoblastic leukemia
1993
Immunoglobulin and T cell receptor gene rearrangements in human lymphoma and leukemia
1987
Near-triploid and near-tetraploid acute lymphoblastic leukemia of childhood
1990
Asynchronous antigen expression in B lineage acute lymphoblastic leukemia
1988
Clinical presentation, karyotypic characterization, and treatment outcome of childhood acute lymphoblastic leukemia with a near-haploid or hypodiploid less than 45 line
1990
Human t(1;19)(q23;p13) pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency
1993
High glucocorticoid receptor content of leukemic blasts is a favorable prognostic factor in childhood acute lymphoblastic leukemia
1993
Clinical presentation, karyotypic characterization, and treatment outcome of childhood acute lymphoblastic leukemia with a near-haploid or hypodiploid less than 45 line
1990